Detalles de la búsqueda
1.
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Prostate;
84(9): 888-892, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561317
2.
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Cancer;
2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38564301
3.
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
Oncologist;
29(5): 450-e725, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452035
4.
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
BMC Cancer;
24(1): 493, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637770
5.
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
Prostate;
83(16): 1602-1609, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644774
6.
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist;
28(8): 737-e693, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36952231
7.
The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer.
J Urol;
209(6): 1120-1131, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789668
8.
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Oncologist;
27(3): 220-227, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274720
9.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist;
27(10): e815-e818, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036607
10.
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
Oncologist;
26(12): 1006-e2129, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423501
11.
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
Oncologist;
26(9): 751-760, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157173
12.
Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma.
J Urol;
205(3): 709-717, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33080152
13.
Landmark Series on Disparities in Surgical Oncology: Melanoma.
Ann Surg Oncol;
28(12): 6986-6993, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191178
14.
The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.
Oncologist;
24(5): 580-583, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30926675
15.
Ipilimumab-induced hypophysitis, a single academic center experience.
Pituitary;
22(5): 488-496, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327112
16.
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.
Oncologist;
28(9): 746-749, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014098
17.
18.
Drug development in metastatic prostate cancer: lessons from ACIS.
Lancet Oncol;
22(11): 1487-1488, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34600603
19.
20.
Eribulin in Cancer Treatment.
Mar Drugs;
13(8): 5016-58, 2015 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26262627